- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03260374
Objective Measures in Cochlear Implant
August 22, 2017 updated by: Dina Mohamed, Assiut University
Objective Measures in Cochlear Implant in Children and Its Correlation to Outcome
One of the main factors affecting the ability to maximize the full potential of a cochlear implant is an accurate map.The goal of mapping is to enable cochlear implant recipients to perceive a desired range of acoustic signals.
The process includes programming of the minimum and the maximum stimulation levels that are based on subjective measurements of thresholds and the most comfortable level .
The use of objective measures in the CI process has greatly contributed to the definition of the dynamic field, as they provide specific values that serve as the basis for the start of the mapping process, especially in cases of infants and young children.
Some examples of these measures are electrically evoked stapedius reflex threshold , neural response telemetry , brainstem auditory evoked potential , and P300, among others.
Study Overview
Status
Unknown
Conditions
Detailed Description
In adult Cochlear implant users, programming is a relatively straightforward task as psychophysical measurements can be explained, and patients quickly understand the link between the mapping process and the output of their system .
In young children or infants, the mapping process is more complex, especially comfort levels.
Setting the threshold level requires the child to respond to the presence or the absence of a sound.
Although the same techniques are used in setting the comfort level, the child is now required to make a judgment about the sound beyond its simple presence or absence.
Young children often lack the attention span, patience, and cognitive and language skills necessary to perform these tasks with good reliability and repeatability .The use of objective measures in the CI process has greatly contributed to the definition of the dynamic field, as they provide specific values that serve as the basis for the start of the mapping process, especially in cases of infants and young children.
Some examples of these measures are electrically evoked stapedius reflex threshold , neural response telemetry , brainstem auditory evoked potential , and P300, among others.The electrically evoked compound action potentials, which are closely related to the electrically evoked brainstem responses, would also show a similar correlation with the behavioral threshold .
Determining threshold levels requires subjective responses to a series of sophisticated psychophysical percepts.
This is often difficult for cochlear implant patients.
However, the neural response telemetry system renders possible the measurement of the compound action potential threshold .
Electric stapedial reflex threshold measurements are performed using the same software platform and electrical stimulus utilized for fitting the cochlear implant .
Thus, stimulus parameters, including pulse duration and repetition rate, can be identical to those used to obtain behavioral judgments for psychophysical levels .For most implant recipients , even the first introduction of electric stimulation from a cochlear implant evokes activity in the auditory brainstem , which can be measured as clear electric auditory brain stem response waveforms .
Therefore this test can be used in the functional evaluation of the auditory system between the time of initial implant activation and after chronic cochlear implant use.
Study Type
Observational
Enrollment (Anticipated)
30
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 6 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
children with sensorineural hearing loss implanted with Medel multi-channel cochlear implant aged 2-6 years
Description
Inclusion Criteria:
- children implanted with Medel multichannel cochlear implant
Exclusion Criteria:
• Any middle ear problem
- Any technical problems with the cochlear implant device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
children with cochlear implant
30 subjects whose age ranges from 2-6 years old who are implanted with Medel multichannel cochlear implant male and female will be included and will undergo:-
|
The electrically evoked compound action potentials, which are closely related to the electrically evoked brainstem responses, would also show a similar correlation with the behavioral threshold.
Determining threshold levels requires subjective responses to a series of sophisticated psychophysical percepts.
This is often difficult for cochlear implant patients.
However, the neural response telemetry system renders possible the measurement of the compound action potential threshold .
electric stapedial reflex threshold measurements are performed using the same software platform and electrical stimulus utilized for fitting the cochlear implant .
Thus, stimulus parameters, including pulse duration and repetition rate, can be identical to those used to obtain behavioral judgments for psychophysical levels
For most implant recipients , even the first introduction of electric stimulation from a cochlear implant evokes activity in the auditory brainstem , which can be measured as clear electric auditory brain stem response waveforms .
Therefore the electric auditory brain stem response test can be used in the functional evaluation of the auditory system between the time of initial implant activation and after chronic cochlear implant use
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arabic language test
Time Frame: 2 years
|
Speech and language assessment in children with cochlear implant
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2017
Primary Completion (Anticipated)
August 31, 2019
Study Completion (Anticipated)
December 30, 2019
Study Registration Dates
First Submitted
August 20, 2017
First Submitted That Met QC Criteria
August 22, 2017
First Posted (Actual)
August 24, 2017
Study Record Updates
Last Update Posted (Actual)
August 24, 2017
Last Update Submitted That Met QC Criteria
August 22, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OMCI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensorineural Hearing Loss
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
University College, LondonUnknownSensorineural Hearing Loss | Sensory Hearing Loss | Sensorineural Hearing Loss in Left Ear | Sensorineural Hearing Loss in Right Ear | Sensorineural HearingUnited Kingdom
-
Fundación Pública Andaluza para la gestión de la...RecruitingBilateral Sensorineural Hearing Loss | Unilateral Sensorineural Hearing LossSpain
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Far East Bio-Tec Co., LtdNot yet recruitingTinnitus | Sudden Sensorineural Hearing Loss (SSNHL)Taiwan
-
Assiut UniversityNot yet recruitingSudden Sensorineural Hearing Loss (SSNHL)Egypt
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
Clinical Trials on Electric compound action potential
-
Stanford UniversityRecruitingChronic Pelvic Pain SyndromeUnited States
-
Yonsei UniversityCompletedAtrial FibrillationKorea, Republic of
-
Sohag UniversityUnknownHearing Loss, Sensorineural, Bilateral
-
Emory UniversityRecruiting
-
Nanjing Yoko Biomedical Co., Ltd.Completed
-
BPGbioCompletedChemotherapy-Induced AlopeciaUnited States
-
Medical University of BialystokCompletedNon Communicable DiseasesPoland
-
Anna Stanhewicz, PhDCompleted
-
Nanjing Yoko Biomedical Co., Ltd.SuspendedAcute Ischemic StrokeChina
-
The Affiliated Hospital of Qingdao UniversityCompleted